New Antimalarials: A Risk-Benefit Analysis

Although more than 40% of the world’s population live in malaria endemic areas, there are only 6 available antimalarial drugs for the treatment of Plasmodium falciparum infections. Three of these have been developed in the last 20 years and are discussed in this review. Mefloquine is relatively well...

Full description

Saved in:
Bibliographic Details
Main Authors: François Nosten, Richard N. Price
Other Authors: Shoklo Malaria Research Unit
Format: Review
Published: 2018
Subjects:
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/17491
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University